ID   KCC2D_MOUSE             Reviewed;         499 AA.
AC   Q6PHZ2; Q3UF87; Q3UQH9; Q5DTK4; Q8CAC5; Q9CZE2;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 169.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type II subunit delta;
DE            Short=CaM kinase II subunit delta;
DE            Short=CaMK-II subunit delta;
DE            EC=2.7.11.17;
GN   Name=Camk2d; Synonyms=Kiaa4163;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   STRAIN=C57BL/6J;
RC   TISSUE=Hypothalamus, Stomach, and Sympathetic ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Fetal brain;
RA   Okazaki N., Kikuno R.F., Ohara R., Inamoto S., Nagase T., Ohara O.,
RA   Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene. The
RT   complete nucleotide sequences of mouse KIAA-homologous cDNAs identified by
RT   screening of terminal sequences of cDNA clones randomly sampled from size-
RT   fractionated libraries.";
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C3H/He; TISSUE=Osteoblast;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=10967556;
RX   DOI=10.1002/1097-4644(20001101)79:2<293::aid-jcb120>3.0.co;2-q;
RA   Hoch B., Wobus A.M., Krause E.G., Karczewski P.;
RT   "delta-Ca(2+)/calmodulin-dependent protein kinase II expression pattern in
RT   adult mouse heart and cardiogenic differentiation of embryonic stem
RT   cells.";
RL   J. Cell. Biochem. 79:293-300(2000).
RN   [5]
RP   FUNCTION IN CARDIAC HYPERTROPHY.
RX   PubMed=12676814; DOI=10.1161/01.res.0000069686.31472.c5;
RA   Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross J. Jr., Bers D.M.,
RA   Brown J.H.;
RT   "The deltaC isoform of CaMKII is activated in cardiac hypertrophy and
RT   induces dilated cardiomyopathy and heart failure.";
RL   Circ. Res. 92:912-919(2003).
RN   [6]
RP   FUNCTION IN PHOSPHORYLATION OF POTASSIUM CHANNEL.
RX   PubMed=15456698; DOI=10.1152/ajpcell.00293.2004;
RA   Sergeant G.P., Ohya S., Reihill J.A., Perrino B.A., Amberg G.C.,
RA   Imaizumi Y., Horowitz B., Sanders K.M., Koh S.D.;
RT   "Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase
RT   II.";
RL   Am. J. Physiol. 288:C304-C313(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330 AND THR-337, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.m800451-mcp200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of electron
RT   capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333; THR-336; THR-337 AND
RP   SER-494, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-318, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [11]
RP   FUNCTION IN MYOCARDIAL REMODELING.
RX   PubMed=15793582; DOI=10.1038/nm1215;
RA   Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., Price E.E. Jr.,
RA   Thiel W., Guatimosim S., Song L.S., Madu E.C., Shah A.N.,
RA   Vishnivetskaya T.A., Atkinson J.B., Gurevich V.V., Salama G., Lederer W.J.,
RA   Colbran R.J., Anderson M.E.;
RT   "Calmodulin kinase II inhibition protects against structural heart
RT   disease.";
RL   Nat. Med. 11:409-417(2005).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF SODIUM CHANNEL.
RX   PubMed=17124532; DOI=10.1172/jci26620;
RA   Wagner S., Dybkova N., Rasenack E.C., Jacobshagen C., Fabritz L.,
RA   Kirchhof P., Maier S.K., Zhang T., Hasenfuss G., Brown J.H., Bers D.M.,
RA   Maier L.S.;
RT   "Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+
RT   channels.";
RL   J. Clin. Invest. 116:3127-3138(2006).
RN   [13]
RP   FUNCTION IN CARDIAC HYPERTROPHIC CARDIOMYOPATHY.
RX   PubMed=19381018; DOI=10.1172/jci38022;
RA   Ling H., Zhang T., Pereira L., Means C.K., Cheng H., Gu Y., Dalton N.D.,
RA   Peterson K.L., Chen J., Bers D., Heller Brown J.;
RT   "Requirement for Ca2+/calmodulin-dependent kinase II in the transition from
RT   pressure overload-induced cardiac hypertrophy to heart failure in mice.";
RL   J. Clin. Invest. 119:1230-1240(2009).
RN   [14]
RP   FUNCTION IN CARDIAC HYPERTROPHY AND REMODELING.
RX   PubMed=19179290; DOI=10.1073/pnas.0813013106;
RA   Backs J., Backs T., Neef S., Kreusser M.M., Lehmann L.H., Patrick D.M.,
RA   Grueter C.E., Qi X., Richardson J.A., Hill J.A., Katus H.A.,
RA   Bassel-Duby R., Maier L.S., Olson E.N.;
RT   "The delta isoform of CaM kinase II is required for pathological cardiac
RT   hypertrophy and remodeling after pressure overload.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:2342-2347(2009).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF L-TYPE CALCIUM CHANNEL, AND INTERACTION WITH
RP   CACNB2.
RX   PubMed=20194790; DOI=10.1073/pnas.0913760107;
RA   Koval O.M., Guan X., Wu Y., Joiner M.L., Gao Z., Chen B., Grumbach I.M.,
RA   Luczak E.D., Colbran R.J., Song L.S., Hund T.J., Mohler P.J.,
RA   Anderson M.E.;
RT   "CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and
RT   afterdepolarizations.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4996-5000(2010).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase involved in the
CC       regulation of Ca(2+) homeostatis and excitation-contraction coupling
CC       (ECC) in heart by targeting ion channels, transporters and accessory
CC       proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release
CC       from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and
CC       K(+) channel transport. Targets also transcription factors and
CC       signaling molecules to regulate heart function. In its activated form,
CC       is involved in the pathogenesis of dilated cardiomyopathy and heart
CC       failure. Contributes to cardiac decompensation and heart failure by
CC       regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+)
CC       channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2
CC       repressor HDAC4, promoting its nuclear export and binding to 14-3-3
CC       protein, and expression of MEF2 and genes involved in the hypertrophic
CC       program. Is essential for left ventricular remodeling responses to
CC       myocardial infarction. In pathological myocardial remodeling acts
CC       downstream of the beta adrenergic receptor signaling cascade to
CC       regulate key proteins involved in ECC. Regulates Ca(2+) influx to
CC       myocytes by binding and phosphorylating the L-type Ca(2+) channel
CC       subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and
CC       regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+
CC       channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart
CC       failure. Phosphorylates phospholamban (PLN/PLB), an endogenous
CC       inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR
CC       Ca(2+) uptake that may be important in frequency-dependent acceleration
CC       of relaxation (FDAR) and maintenance of contractile function during
CC       acidosis. May participate in the modulation of skeletal muscle function
CC       in response to exercise, by regulating SR Ca(2+) transport through
CC       phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling
CC       factor. {ECO:0000269|PubMed:12676814, ECO:0000269|PubMed:15456698,
CC       ECO:0000269|PubMed:15793582, ECO:0000269|PubMed:17124532,
CC       ECO:0000269|PubMed:19179290, ECO:0000269|PubMed:19381018,
CC       ECO:0000269|PubMed:20194790}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves intrasteric
CC       autoinhibition and allows autophosphorylation of Thr-287 which turns
CC       the kinase in a constitutively active form and confers to the kinase a
CC       Ca(2+)-independent activity.
CC   -!- SUBUNIT: CAMK2 is composed of 4 different chains: alpha (CAMK2A), beta
CC       (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different isoforms
CC       assemble into homo- or heteromultimeric holoenzymes composed of 12
CC       subunits with two hexameric rings stacked one on top of the other.
CC       Interacts with RRAD (By similarity). Interacts with CACNB2.
CC       {ECO:0000250, ECO:0000269|PubMed:20194790}.
CC   -!- INTERACTION:
CC       Q6PHZ2; Q9JJ28: Flii; NbExp=5; IntAct=EBI-2308458, EBI-7996161;
CC       Q6PHZ2; E9Q401: Ryr2; NbExp=2; IntAct=EBI-2308458, EBI-643628;
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000305};
CC       Peripheral membrane protein {ECO:0000305}; Cytoplasmic side
CC       {ECO:0000305}. Sarcoplasmic reticulum membrane {ECO:0000305};
CC       Peripheral membrane protein {ECO:0000305}; Cytoplasmic side
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Delta 2;
CC         IsoId=Q6PHZ2-1; Sequence=Displayed;
CC       Name=2; Synonyms=Delta 6;
CC         IsoId=Q6PHZ2-2; Sequence=VSP_023103, VSP_023102;
CC       Name=3; Synonyms=Delta 10;
CC         IsoId=Q6PHZ2-4; Sequence=VSP_023101, VSP_023103, VSP_023102;
CC       Name=4; Synonyms=Delta 5;
CC         IsoId=Q6PHZ2-5; Sequence=VSP_023100, VSP_023103, VSP_023102;
CC   -!- TISSUE SPECIFICITY: Expressed in cardiac muscle and skeletal muscle.
CC       Isoform Delta 2, isoform Delta 6, isoform Delta 6 and isoform Delta 10
CC       are expressed in cardiac muscle. Isoform Delta 2 is expressed in
CC       skeletal muscle. {ECO:0000269|PubMed:10967556}.
CC   -!- DOMAIN: The CAMK2 protein kinases contain a unique C-terminal subunit
CC       association domain responsible for oligomerization.
CC   -!- PTM: Autophosphorylation of Thr-287 following activation by
CC       Ca(2+)/calmodulin. Phosphorylation of Thr-287 locks the kinase into an
CC       activated state (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Mice overexpressing CaMK2D develop a dilated
CC       cardiomyopathy, enlarged myocytes with reduced contractility and
CC       altered Ca(2+) handling, and die prematurely in PubMed:12676814.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD90304.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK039076; BAC30232.1; -; mRNA.
DR   EMBL; AK012702; BAB28422.1; -; mRNA.
DR   EMBL; AK142435; BAE25062.1; -; mRNA.
DR   EMBL; AK148840; BAE28674.1; -; mRNA.
DR   EMBL; AK220516; BAD90304.1; ALT_INIT; mRNA.
DR   EMBL; BC052894; AAH52894.1; -; mRNA.
DR   CCDS; CCDS17823.1; -. [Q6PHZ2-1]
DR   CCDS; CCDS51065.1; -. [Q6PHZ2-2]
DR   CCDS; CCDS80015.1; -. [Q6PHZ2-5]
DR   CCDS; CCDS80016.1; -. [Q6PHZ2-4]
DR   RefSeq; NP_001020609.1; NM_001025438.2. [Q6PHZ2-1]
DR   RefSeq; NP_001020610.1; NM_001025439.2.
DR   RefSeq; NP_001280592.1; NM_001293663.1. [Q6PHZ2-5]
DR   RefSeq; NP_001280593.1; NM_001293664.1. [Q6PHZ2-4]
DR   RefSeq; NP_076302.1; NM_023813.4. [Q6PHZ2-2]
DR   PDB; 6BAB; X-ray; 1.91 A; A/B/C/D=3-301.
DR   PDBsum; 6BAB; -.
DR   AlphaFoldDB; Q6PHZ2; -.
DR   SMR; Q6PHZ2; -.
DR   BioGRID; 223798; 22.
DR   DIP; DIP-47638N; -.
DR   IntAct; Q6PHZ2; 26.
DR   MINT; Q6PHZ2; -.
DR   STRING; 10090.ENSMUSP00000102009; -.
DR   iPTMnet; Q6PHZ2; -.
DR   MetOSite; Q6PHZ2; -.
DR   PhosphoSitePlus; Q6PHZ2; -.
DR   SwissPalm; Q6PHZ2; -.
DR   EPD; Q6PHZ2; -.
DR   jPOST; Q6PHZ2; -.
DR   MaxQB; Q6PHZ2; -.
DR   PeptideAtlas; Q6PHZ2; -.
DR   PRIDE; Q6PHZ2; -.
DR   ProteomicsDB; 269245; -. [Q6PHZ2-1]
DR   ProteomicsDB; 269246; -. [Q6PHZ2-2]
DR   ProteomicsDB; 269247; -. [Q6PHZ2-4]
DR   ProteomicsDB; 269248; -. [Q6PHZ2-5]
DR   DNASU; 108058; -.
DR   Ensembl; ENSMUST00000066466; ENSMUSP00000063359; ENSMUSG00000053819. [Q6PHZ2-4]
DR   Ensembl; ENSMUST00000106400; ENSMUSP00000102008; ENSMUSG00000053819. [Q6PHZ2-2]
DR   Ensembl; ENSMUST00000106402; ENSMUSP00000102010; ENSMUSG00000053819. [Q6PHZ2-5]
DR   Ensembl; ENSMUST00000199300; ENSMUSP00000143504; ENSMUSG00000053819. [Q6PHZ2-1]
DR   GeneID; 108058; -.
DR   KEGG; mmu:108058; -.
DR   UCSC; uc008rgh.2; mouse. [Q6PHZ2-1]
DR   UCSC; uc008rgl.2; mouse. [Q6PHZ2-2]
DR   UCSC; uc008rgn.2; mouse. [Q6PHZ2-5]
DR   UCSC; uc008rgo.2; mouse. [Q6PHZ2-4]
DR   CTD; 817; -.
DR   MGI; MGI:1341265; Camk2d.
DR   VEuPathDB; HostDB:ENSMUSG00000053819; -.
DR   eggNOG; KOG0033; Eukaryota.
DR   GeneTree; ENSGT00940000159769; -.
DR   InParanoid; Q6PHZ2; -.
DR   PhylomeDB; Q6PHZ2; -.
DR   BRENDA; 2.7.11.17; 3474.
DR   Reactome; R-MMU-3371571; HSF1-dependent transactivation.
DR   Reactome; R-MMU-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-MMU-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-MMU-5578775; Ion homeostasis.
DR   Reactome; R-MMU-5673000; RAF activation.
DR   Reactome; R-MMU-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-MMU-877300; Interferon gamma signaling.
DR   Reactome; R-MMU-936837; Ion transport by P-type ATPases.
DR   BioGRID-ORCS; 108058; 1 hit in 75 CRISPR screens.
DR   ChiTaRS; Camk2d; mouse.
DR   PRO; PR:Q6PHZ2; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; Q6PHZ2; protein.
DR   Bgee; ENSMUSG00000053819; Expressed in anterior amygdaloid area and 249 other tissues.
DR   ExpressionAtlas; Q6PHZ2; baseline and differential.
DR   Genevisible; Q6PHZ2; MM.
DR   GO; GO:0043194; C:axon initial segment; IDA:MGI.
DR   GO; GO:0005954; C:calcium- and calmodulin-dependent protein kinase complex; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0014704; C:intercalated disc; IDA:MGI.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030315; C:T-tubule; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; ISO:MGI.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; ISS:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; ISO:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:MGI.
DR   GO; GO:0004672; F:protein kinase activity; ISO:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:MGI.
DR   GO; GO:0019871; F:sodium channel inhibitor activity; ISO:MGI.
DR   GO; GO:0031432; F:titin binding; ISO:MGI.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IDA:MGI.
DR   GO; GO:0086003; P:cardiac muscle cell contraction; ISS:BHF-UCL.
DR   GO; GO:0060048; P:cardiac muscle contraction; IDA:MGI.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; ISO:MGI.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; ISO:MGI.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; ISO:MGI.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:MGI.
DR   GO; GO:1902306; P:negative regulation of sodium ion transmembrane transport; ISO:MGI.
DR   GO; GO:2000650; P:negative regulation of sodium ion transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; ISO:MGI.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISS:UniProtKB.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; ISO:MGI.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:MGI.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; ISO:MGI.
DR   GO; GO:0035022; P:positive regulation of Rac protein signal transduction; ISO:MGI.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; ISO:MGI.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:MGI.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:1902514; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; ISO:MGI.
DR   GO; GO:0098901; P:regulation of cardiac muscle cell action potential; ISO:MGI.
DR   GO; GO:0010649; P:regulation of cell communication by electrical coupling; ISO:MGI.
DR   GO; GO:0060341; P:regulation of cellular localization; ISS:UniProtKB.
DR   GO; GO:0003254; P:regulation of membrane depolarization; ISO:MGI.
DR   GO; GO:1903076; P:regulation of protein localization to plasma membrane; ISO:MGI.
DR   GO; GO:1901897; P:regulation of relaxation of cardiac muscle; IGI:BHF-UCL.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISO:MGI.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IDA:MGI.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; ISS:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; ISO:MGI.
DR   InterPro; IPR013543; Ca/CaM-dep_prot_kinase-assoc.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR032710; NTF2-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF08332; CaMKII_AD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54427; SSF54427; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Calmodulin-binding; Cell membrane; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Sarcoplasmic reticulum;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557"
FT   CHAIN           2..499
FT                   /note="Calcium/calmodulin-dependent protein kinase type II
FT                   subunit delta"
FT                   /id="PRO_0000277817"
FT   DOMAIN          14..272
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          283..292
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          291..301
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        136
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         20..28
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         43
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557"
FT   MOD_RES         287
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557, ECO:0000305"
FT   MOD_RES         306
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         307
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557"
FT   MOD_RES         318
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19131326"
FT   MOD_RES         331
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         336
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         337
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19131326,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         404
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557"
FT   MOD_RES         490
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13557"
FT   MOD_RES         494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   VAR_SEQ         328
FT                   /note="K -> KINNKANVVTSPKENIPTPALEPQTTVIHNPDGNK (in isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:16141072, ECO:0000303|Ref.2"
FT                   /id="VSP_023100"
FT   VAR_SEQ         329
FT                   /note="E -> EPQTTVIHNPDGNKE (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_023101"
FT   VAR_SEQ         478
FT                   /note="K -> N (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072, ECO:0000303|Ref.2"
FT                   /id="VSP_023103"
FT   VAR_SEQ         479..499
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072, ECO:0000303|Ref.2"
FT                   /id="VSP_023102"
FT   CONFLICT        123..125
FT                   /note="SVN -> AVL (in Ref. 1; BAC30232)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129..132
FT                   /note="LNGI -> QMGV (in Ref. 1; BAC30232)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="A -> V (in Ref. 1; BAC30232)"
FT                   /evidence="ECO:0000305"
FT   STRAND          13..23
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   STRAND          26..33
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   TURN            34..37
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   STRAND          38..46
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           54..67
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   STRAND          76..81
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   STRAND          83..91
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           98..102
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           110..129
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           139..141
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           183..186
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           194..209
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           219..228
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           237..240
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           243..252
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   TURN            257..259
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           263..266
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           270..273
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           275..278
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   HELIX           285..299
FT                   /evidence="ECO:0007829|PDB:6BAB"
FT   CONFLICT        Q6PHZ2-2:478
FT                   /note="N -> K (in Ref. 1; BAE25062)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   499 AA;  56369 MW;  62999FBAB98120CE CRC64;
     MASTTTCTRF TDEYQLFEEL GKGAFSVVRR CMKIPTGQEY AAKIINTKKL SARDHQKLER
     EARICRLLKH PNIVRLHDSI SEEGFHYLVF DLVTGGELFE DIVAREYYSE ADASHCIQQI
     LESVNHCHLN GIVHRDLKPE NLLLASKSKG AAVKLADFGL AIEVQGDQQA WFGFAGTPGY
     LSPEVLRKDP YGKPVDMWAC GVILYILLVG YPPFWDEDQH RLYQQIKAGA YDFPSPEWDT
     VTPEAKDLIN KMLTINPAKR ITASEALKHP WICQRSTVAS MMHRQETVDC LKKFNARRKL
     KGAILTTMLA TRNFSAAKSL LKKPDGVKES TESSNTTIED EDVKARKQEI IKVTEQLIEA
     INNGDFEAYT KICDPGLTAF EPEALGNLVE GMDFHRFYFE NALSKSNKPI HTIILNPHVH
     LVGDDAACIA YIRLTQYMDG SGMPKTMQSE ETRVWHRRDG KWQNVHFHRS GSPTVPIKPP
     CIPNGKENFS GGTSLWQNI
//
